Skip to main content

Polygon Management Ltd.

SEC CIK
0001515070
Latest filing
Aug 12, 2026

Holdings in Q3 2025

Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.

Institution overview
Positions
43
+7 vs. Q2 2025
Portfolio value
$688.6M
+$134.2M (+24.2%) vs. Q2 2025
Filed
Nov 14, 2025
SEC
Holdings of Polygon Management Ltd. in Q3 2025
SecurityClassSharesValue% of portfolioShare changeActionHistory
PATHUiPath, Inc.Stock16,950,000$226.8M32.9%+3,227,756+23.5%AddedHistory
Alibaba Group Hldg Ltd01609WBG6NOTE 0.500% 6/0–$174.8M25.4%–––
KGEIKolibri Global Energy Inc.COM NEW7,070,568$39.2M5.7%+1,7110.0%AddedHistory
Lithium Amers Corp New53680QAA6NOTE 1.750% 1/1–$24.6M3.6%–––
LYFTLyft, Inc.CL A COM1,000,000$22.0M3.2%00.0%UnchangedHistory
Cable One, Inc.12685JAE5NOTE 3/1–$20.8M3.0%–New–
Progress Software Corp743312AB6NOTE 1.000% 4/1–$20.6M3.0%–New–
Oatly Group AB67421JAC2NOTE 9.250% 9/1–$18.4M2.7%–––
CXMSprinklr, Inc.CL A2,200,000$17.0M2.5%00.0%UnchangedHistory
AUTLAutolus Therapeutics plcSPON ADS9,500,000$15.5M2.2%00.0%UnchangedHistory
WKWorkiva IncCOM CL A150,000$12.9M1.9%00.0%UnchangedHistory
First Majestic Silver Corp32076VAD5NOTE 0.375% 1/1–$7.97M1.2%–––
CLDXCelldex Therapeutics, Inc.COM NEW303,600$7.85M1.1%−12,550−4.0%ReducedHistory
Celcuity Inc.15102KAA8NOTE 2.750% 8/0–$7.44M1.1%–New–
TARSTarsus Pharmaceuticals, Inc.COM125,000$7.43M1.1%−125,000−50.0%ReducedHistory
ANNXAnnexon, Inc.COM2,112,455$6.44M0.9%−697,545−24.8%ReducedHistory
iShares Tr464288513IBOXX HI YD ETF72,961$5.92M0.9%+4,301+6.3%Added–
AXSMAxsome Therapeutics, Inc.COM46,456$5.64M0.8%+4,925+11.9%AddedHistory
PHVSPharvaris N.V.COM194,612$4.86M0.7%+6,512+3.5%AddedHistory
SRRKScholar Rock Holding CorpCOM117,882$4.39M0.6%+14,400+13.9%AddedHistory
TECXTectonic Therapeutic, Inc.COM243,728$3.82M0.6%+14,896+6.5%AddedHistory
AMLXAmylyx Pharmaceuticals, Inc.COM258,242$3.51M0.5%+39,492+18.1%AddedHistory
MBXMBX Biosciences, Inc.COM177,840$3.11M0.5%+177,840NewHistory
IMVTImmunovant, Inc.COM188,379$3.04M0.4%+40,562+27.4%AddedHistory
DYNDyne Therapeutics, Inc.COM223,181$2.82M0.4%+84,806+61.3%AddedHistory
ARWRArrowhead Pharmaceuticals, Inc.COM81,841$2.82M0.4%+81,841NewHistory
ALKSAlkermes plc.SHS89,612$2.69M0.4%+73,980+473.3%AddedHistory
ABVXAbivax S.A.SPONSORED ADS30,000$2.55M0.4%+30,000NewHistory
SNOWSnowflake Inc.Stock10,000$2.26M0.3%00.0%UnchangedHistory
ACADAcadia Pharmaceuticals IncCOM86,071$1.84M0.3%−75,325−46.7%ReducedHistory
HBMHudbay Minerals Inc.COM117,500$1.78M0.3%+10,500+9.8%AddedHistory
CCJCameco CorpStock16,015$1.34M0.2%−3,265−16.9%ReducedHistory
RLAYRelay Therapeutics, Inc.COM223,123$1.16M0.2%−475,877−68.1%ReducedHistory
FOLDAmicus Therapeutics, Inc.COM121,212$955.2K0.1%+121,212NewHistory
KRYSKrystal Biotech, Inc.COM4,870$859.7K0.1%+4,870NewHistory
TECKTeck Resources LtdCL B18,068$793.0K0.1%+11,700+183.7%AddedHistory
KROSKeros Therapeutics, Inc.COM43,000$680.3K0.1%−85,000−66.4%ReducedHistory
LARLithium Argentina AGStock200,000$668.0K0.1%+200,000NewHistory
RAREUltragenyx Pharmaceutical Inc.COM17,718$533.0K0.1%+17,718NewHistory
WBIWaterBridge Infrastructure LLCCL A SHS REPSTG20,000$504.4K0.1%+20,000NewHistory
NXENexGen Energy Ltd.COM42,000$375.9K0.1%+42,000NewHistory
Diana Shipping Inc.Y2066G138*W EXP 12/14/202233,400$22.8K<0.1%−67,800−22.5%Reduced–
Sonder Holdings Inc.83542D110CALL EXP31JAN2218,898$204<0.1%00.0%Unchanged–

Options (1)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Polygon Management Ltd. in Q3 2025
SecurityClassPutsCalls
iShares Tr464288513IBOXX HI YD ETF$59.0M–

Sold out since Q2 2025 (5)

Positions held at the end of Q2 2025 that are gone from this filing.

Positions of Polygon Management Ltd. sold out since Q2 2025
SecurityClassShares in Q2 2025Value in Q2 2025% of portfolio in Q2 2025History
JD.com, Inc.47215PAJ5NOTE 0.250% 6/0–$20.9M3.8%–
Trip.com Group Ltd89677QAB3NOTE 0.750% 6/1–$11.1M2.0%–
Cytokinetics Inc23282WAC4NOTE 3.500% 7/0–$5.39M1.0%–
SQMChemical & Mining Co of Chile IncSPON ADR SER B7,700$271.6K<0.1%History
YARWYarrow Bioscience, Inc.COM115,384$190.4K<0.1%History